Étude des paramètres nutritionnels des patients suivis au CRCM pédiatrique du CHU de Bordeaux dénutris ou à risque de dénutrition

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  2018-04-24

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes

  2017cited by this paper
• Oral calorie supplements for cystic fibrosis.

  2017cited by this paper
• Macronutrient intake in preschoolers with cystic fibrosis and the relationship between macronutrients and growth.

  2017cited by this paper
• CFTR silencing in pancreatic β-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response.

  2016influential reference
• [New therapeutic developments in cystic fibrosis].

  2016cited by this paper
• Drug therapies for reducing gastric acidity in people with cystic fibrosis.

  2016cited by this paper
• Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

  2016influential reference
• [Liver disease, gastrointestinal complications, nutritional management and feeding disorders in pediatric cystic fibrosis].

  2016cited by this paper
• ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis.

  2016influential reference
• [Pancreatic infringement exocrine and endocrine in cystic fibrosis].

  2016influential reference
• [Epidemiological trends of cystic fibrosis in France: 10-year perspective].

  2016cited by this paper
• Management of pancreatic, gastrointestinal and liver complications in adult cystic fibrosis.

  2015influential reference
• EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2015. Scientific Opinion on Dietary Reference Values for calcium

  2015cited by this paper
• Behavioral and nutritional treatment for preschool-aged children with cystic fibrosis: a randomized clinical trial.

  2015cited by this paper
• [National French guidelines for management of infants with cystic fibrosis].

  2014cited by this paper
• Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.

  2014cited by this paper
• CFTR structure and cystic fibrosis.

  2014cited by this paper
• [Therapeutic update in cystic fibrosis].

  2014cited by this paper
• Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis

  2014cited by this paper
• Nutrition et mucoviscidose : de la prise en charge préventive au support nutritionnel

  2014cited by this paper
• Gastrointestinal complications of cystic fibrosis.

  2013influential reference
• Early lung disease in cystic fibrosis.

  2013cited by this paper
• Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study.

  2013cited by this paper
• Nutritional intervention in patients with Cystic Fibrosis: a systematic review.

  2013influential reference
• Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis.

  2013cited by this paper
• Mechanisms of Increased Gastroesophageal Reflux in Patients With Cystic Fibrosis

  2012cited by this paper
• Gastroesophageal reflux disease in lung transplant patients with cystic fibrosis.

  2012cited by this paper
• Nutritional outcomes following gastrostomy in children with cystic fibrosis

  2012cited by this paper
• Drug therapies for reducing gastric acidity in people with cystic fibrosis.

  2012cited by this paper
• Mucoviscidose: organisation de la prise en charge

  2012cited by this paper
• [Genetics and modifier genes, atypical and rare forms].

  2012influential reference
• Ursodeoxycholic acid for cystic fibrosis-related liver disease.

  2012cited by this paper
• Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease.

  2011influential reference
• Assessment of growth: variations according to references and growth parameters used.

  2011cited by this paper
• [Non-invasive prenatal diagnosis of cystic fibrosis].

  2011cited by this paper
• Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program.

  2011cited by this paper
• Cystic fibrosis-associated liver disease.

  2010cited by this paper
• Defining DIOS and Constipation in Cystic Fibrosis With a Multicentre Study on the Incidence, Characteristics, and Treatment of DIOS

  2010cited by this paper
• Cystic Fibrosis

  2009influential reference
• Randomized clinical trial of behavioral intervention and nutrition education to improve caloric intake and weight in children with cystic fibrosis.

  2009cited by this paper
• Validation of a Nutrition Risk Screening Tool for Children and Adolescents With Cystic Fibrosis Ages 2–20 Years

  2008cited by this paper
• [The French nationwide cystic fibrosis newborn screening program: strategy and results].

  2008influential reference
• Physiopathologie de la mucoviscidose

  2007cited by this paper
• Update on enteral nutrition support for cystic fibrosis.

  2007cited by this paper
• Thérapie génique et cellulaire des maladies respiratoires

  2007cited by this paper
• Long Term Nutritional Rehabilitation by Gastrostomy in Israeli Patients with Cystic Fibrosis: Clinical Outcome in Advanced Pulmonary Disease

  2006cited by this paper
• [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].

  2006cited by this paper
• Stratégies de prise en charge nutritionnelle de l'enfant et de l'adulte jeune atteint de mucoviscidose

  2005cited by this paper
• Atteinte hépatique de la mucoviscidose

  2005cited by this paper
• Mealtime behaviors in families of infants and toddlers with cystic fibrosis.

  2005cited by this paper
• Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis.

  2005cited by this paper
• Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration

  2004cited by this paper
• [Cystic fibrosis: relationship between genotype and phenotype].

  2003influential reference
• Caloric intake and eating behavior in infants and toddlers with cystic fibrosis.

  2002influential reference
• Energy cost of physical activity in cystic fibrosis

  2001cited by this paper
• Energy Supplements Rich in Linoleic Acid Improve Body Weight and Essential Fatty Acid Status of Cystic Fibrosis Patients

  2000cited by this paper
• Enteral tube feeding for cystic fibrosis.

  2000influential reference
• Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis

  2000cited by this paper
• CFTR is a conductance regulator as well as a chloride channel.

  1999cited by this paper
• Increased resting energy expenditure is related to plasmaTNF-α concentration in stable COPD patients

  1999cited by this paper
• Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis

  1998cited by this paper
• Total Energy Expenditure in stable patients with Cystic Fibrosis

  1998cited by this paper
• Nutrition intervention for weight gain in cystic fibrosis: a meta analysis.

  1998cited by this paper
• Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study.

  1998cited by this paper
• Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung.

  1997cited by this paper
• Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis.

  1996influential reference
• Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?

  1993cited by this paper
• Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells.

  1993cited by this paper
• Prediction of mortality in patients with cystic fibrosis.

  1992cited by this paper
• Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.

  1992cited by this paper
• Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene

  1992cited by this paper
• Detection of over 98% cystic fibrosis mutations in a Celtic population

  1992influential reference
• Assessment of total energy expenditure in free-living patients with cystic fibrosis.

  1991cited by this paper
• The cystic fibrosis gene and resting energy expenditure.

  1991influential reference
• Body Mass Index variations: centiles from birth to 87 years.

  1991cited by this paper
• Energy content of stools in normal healthy controls and patients with cystic fibrosis.

  1991cited by this paper
• Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA

  1989cited by this paper
• A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.

  1988cited by this paper
• Energy expenditure of patients with cystic fibrosis.

  1987cited by this paper
• Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption.

  1982cited by this paper
• Classification and definition of protein-calorie malnutrition.

  1972cited by this paper
• CYSTIC FIBROSIS OF THE PANCREAS

  1969cited by this paper

• No citing papers are available for this paper.